Dan Peer
Dan Peer
Prof. of NanoMedicine and Immunology, Tel Aviv University
Dirección de correo verificada de post.tau.ac.il
Título
Citado por
Citado por
Año
Nanocarriers as an emerging platform for cancer therapy
D Peer, JM Karp, S Hong, OC Farokhzad, R Margalit, R Langer
Nature nanotechnology 2 (12), 751-760, 2007
74362007
Progress and challenges towards targeted delivery of cancer therapeutics
D Rosenblum, N Joshi, W Tao, JM Karp, D Peer
Nature communications 9 (1), 1-12, 2018
5752018
Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target
D Peer, EJ Park, Y Morishita, CV Carman, M Shimaoka
Science 319 (5863), 627-630, 2008
4932008
Nanoparticle hydrophobicity dictates immune response
DF Moyano, M Goldsmith, DJ Solfiell, D Landesman-Milo, OR Miranda, ...
Journal of the American Chemical Society 134 (9), 3965-3967, 2012
3242012
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1
D Peer, P Zhu, CV Carman, J Lieberman, M Shimaoka
Proceedings of the National Academy of Sciences 104 (10), 4095-4100, 2007
2772007
Polysaccharides as building blocks for nanotherapeutics
S Mizrahy, D Peer
Chemical Society Reviews 41 (7), 2623-2640, 2012
2732012
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
R Kedmi, N Ben-Arie, D Peer
Biomaterials 31 (26), 6867-6875, 2010
2692010
Loading mitomycin C inside long circulating hyaluronan targeted nano‐liposomes increases its antitumor activity in three mice tumor models
D Peer, R Margalit
International Journal of Cancer 108 (5), 780-789, 2004
2452004
Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models
D Peer, R Margalit
Neoplasia (New York, NY) 6 (4), 343, 2004
2302004
Nanoparticles for imaging, sensing, and therapeutic intervention
LK Bogart, G Pourroy, CJ Murphy, V Puntes, T Pellegrino, D Rosenblum, ...
ACS nano 8 (4), 3107-3122, 2014
2152014
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice
SS Kim, D Peer, P Kumar, S Subramanya, H Wu, D Asthana, K Habiro, ...
Molecular therapy 18 (2), 370-376, 2010
2072010
Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response
S Mizrahy, SR Raz, M Hasgaard, H Liu, N Soffer-Tsur, K Cohen, R Dvash, ...
Journal of controlled release 156 (2), 231-238, 2011
1742011
Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions
TJ Anchordoquy, Y Barenholz, D Boraschi, M Chorny, P Decuzzi, ...
ACS nano 11 (1), 12-18, 2017
1642017
RNAi-based nanomedicines for targeted personalized therapy
A Daka, D Peer
Advanced drug delivery reviews 64 (13), 1508-1521, 2012
1452012
Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
I Rivkin, K Cohen, J Koffler, D Melikhov, D Peer, R Margalit
Biomaterials 31 (27), 7106-7114, 2010
1452010
Special delivery: targeted therapy with small RNAs
D Peer, J Lieberman
Gene therapy 18 (12), 1127-1133, 2011
1442011
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles
ZR Cohen, S Ramishetti, N Peshes-Yaloz, M Goldsmith, A Wohl, Z Zibly, ...
ACS nano 9 (2), 1581-1591, 2015
1072015
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models
D Peer, Y Dekel, D Melikhov, R Margalit
Cancer Research 64 (20), 7562-7569, 2004
1002004
Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes
D Peer, A Florentin, R Margalit
Biochimica et Biophysica Acta (BBA)-Biomembranes 1612 (1), 76-82, 2003
972003
Corneal gene therapy
EA Klausner, D Peer, RL Chapman, RF Multack, SV Andurkar
Journal of Controlled Release 124 (3), 107-133, 2007
922007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20